REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/05/2025
Back to search
Official data from USPTO
LELLOKEY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
05/06/2025
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
09/26/2019
Registration date
05/05/2020
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/05/2020
Last transaction
05/06/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
Summit, NJ
Examiner
MARTIN, CHRISTINE
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
C. C. (pessoa física)
Representatives
Marilyn F. Kelly Bristol-Myers Squibb Company
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for use in the treatment of cancer and auto-immune diseasesdiseases in the fields of oncologyimmunology and inflammation; pharmaceutical preparationscytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; pharmaceutical preparationspreparations for use in the treatment of tumors; pharmaceutical and biological preparations for immunotherapyincluding T Cell therapy; cells for medical or clinical use; diagnostic kits consisting primarily of cells for medical or clinical use
Publications
History of USPTO decisions and trademark events.
24 publications found
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/09/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/09/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
12/09/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/09/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/09/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/09/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
05/05/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/18/2020
PUBO
PUBLISHED FOR OPPOSITION
02/18/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/29/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/13/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/11/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/11/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
01/07/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/02/2020
GNSL
LETTER OF SUSPENSION E-MAILED
01/02/2020
CNSL
SUSPENSION LETTER WRITTEN
01/02/2020
DOCK
ASSIGNED TO EXAMINER
12/30/2019
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
10/08/2019
ALIE
ASSIGNED TO LIE
10/07/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/01/2019
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
09/30/2019
NWAP
NEW APPLICATION ENTERED
09/30/2019
Continuous trademark protection
Get notified about every new filing that threatens LELLOKEY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.